Quick Answer
Ping An Biomedical Co., Ltd. reported Diluted EPS of $0.69 per share (loss) for fiscal year 2025.
Ping An Biomedical Co., Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.69 | -885.7% |
| 2024 | -$0.07 | -16.7% |
| 2023 | -$0.06 | — |
- Ping An Biomedical Co., Ltd. showed a decrease of -885.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, Ping An Biomedical Co., Ltd.’s diluted eps has declined by 1050.0% (from $0.06 per share (loss) to $0.69 per share (loss)).
- The most recent figure is from Ping An Biomedical Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: